Article
Target disruption of the mutant beta-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype.
Oncogene - 29 Aug 2002
Sekine Shigeki, Shibata Tatsuhiro, Sakamoto Michiie, Hirohashi Setsuo
Abstract excerpt
Most colorectal carcinomas harbor genetic alterations that result in stabilization of beta-catenin. A colorectal carcinoma cell line, HCT116, which has both mutated and wild-type beta-catenin genes, was engineered by homologous recombination to investigate the significance of beta-catenin gene mutation. As expected, the mutant allele-targeted clones showed decreased beta-catenin expression and downregulation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
